Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
Related Posts
Pope remains in ‘critical’ condition after ‘respiratory crisis’
Pope Francis is “more unwell than yesterday”, the Vatican says, adding his prognosis “remains guarded”.
First case of more contagious mpox found outside Africa
Sweden’s public health agency records what it says is the first case of a contagious new variant of mpox outside…
Qwen Open Sources the Powerful, Diverse, and Practical Qwen2.5-Coder Series (0.5B/1.5B/3B/7B/14B/32B)
In the world of software development, there is a constant need for more intelligent, capable, and specialized coding language models.…